REFS™
Reverse Engineering, Forward Simulation (REFS), our patented causal machine learning and simulation platform, goes beyond the superficial data correlations of predictive analytics and deep learning to reveal the drivers of disease progression and individual patient response to drugs.
The unique simulation capabilities of REFS empower scientists to deliver new insights and make better decisions by answering the what if questions beyond the scope of conventional AI.
Fast, scalable and highly interactive, REFS includes built-in biopharma functions found in no other platform. Data-agnostic, REFS is compatible with virtually any data type, from EHRs, clinical trials, ‘omics to claims and can work with various sized data sets data sets.